Enhancing Tumor Cell Response to Chemotherapy Through Nanoparticle-Mediated Codelivery of siRNA and Cisplatin Prodrug

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1303958110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Liposomal Codelivery of an SN38 Prodrug and a Survivin siRNA for Tumor Therapy

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Nanoparticle-Mediated Co-Delivery of Small Interfering RNA and Cisplatin Prodrug

Science-Business eXchange
2013English

Association of Metallothionein Expression and Clinical Response to Cisplatin Based Chemotherapy in Testicular Germ Cell Tumors

Central European Journal of Urology
Urology
2015English

Paclitaxel Prodrug Based Mixed Micelles for Tumor-Targeted Chemotherapy

RSC Advances
ChemistryChemical Engineering
2018English

Down-Regulation of MEF2D via HBc Nanoparticle Mediated siRNA Inhibits HepG2 Cell Proliferation in Vitro

2015English

Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy

Hereditary Cancer in Clinical Practice
OncologyGenetics
2015English

Nanoparticle Modulation of the Tumor Microenvironment Enhances Therapeutic Efficacy of Cisplatin

Journal of Controlled Release
Pharmaceutical Science
2015English

Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance

Frontiers in Immunology
AllergyImmunology
2017English

Nanoparticle-Mediated Delivery of a Rapidly Activatable Prodrug of SN-38 for Neuroblastoma Therapy

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy